ADAM12 and gastric cancer: This finding is consistent with the findings of other studies showing that the expression of ADAM10, ADAM12 and ADAM17 is increased in gastric cancer tissues, and that increased expression of those in gastric cancer tissues is associated with poor survival in patients with gastric cancer5,41–46.